Duogenic Stemcells Corporation

Duogenic Stemcells Corporation — FDA 510(k) Submissions

Duogenic Stemcells Corporation has submitted 1 FDA 510(k) premarket notifications since 2024, of which 1 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Media, Culture, Ex Vivo, Tissue And Cell . Use the specialty filter in the sidebar to narrow results.